Editorial
The price of innovation: a primer on high risk, high reward surgery
Abstract
Difficult problems stimulate the development of novel therapies which more often than not are high-risk due to the nature of the disease process. Rare diseases offer few opportunities to refine a technique or protocol. Diseases that leave patients in critical and unstable conditions leave little margin for error.
